Goros的問題，透過圖書和論文來找解法和答案更準確安心。 我們找到下列問答集和整理懶人包

Goros進入發燒排行的影片

探討人類前列腺癌及口服咸豐草萃取物與小鼠腸道菌叢之關聯

為了解決Goros的問題，作者黃品瑜 這樣論述：

摘要 iAbstract iiContents iiiList of Table viList of Figure viiChapter 1. Introduction 11.1 Prostate cancer and effect of Bidens pilosa extract in prostate cancer treatment 11.2 Gut microbiota and cancer 11.3 Gut microbiota diversity in cancer patients 21.4 The differential

abundant bacteria 21.5 Summary 3Chapter 2. Materials and Methods 42.1 Mice strain and experimental mice care 42.1.1 Exp. 1 microbiota from prostate tumor-bearing mice vs. tumor-free mice 42.1.2 Exp. 2 microbiota from Bidens Pilosa extract treated prostate tumor-bearing mice vs. witho

ut treated tumor-bearing mice 42.2 Sample collection and DNA extract 42.2.1 Sample collection for Exp 1. Microbiota from prostate tumor-bearing mice vs. tumor-free mice 42.2.2 Sample collection for Exp 2. Microbiota from Bidens pilosa extract treated prostate tumor-bearing mice vs. without

treated tumor-bearing mice 42.2.3 DNA extract 52.3 16S rRNA gene amplification and sequencing 52.4 Bioinformatics analysis 52.4.1 Sequence quality control and ASVs table construction 52.4.2 Biodiversity analysis and taxonomy classification 52.4.3 Statistical analysis 62.4.4 Diff

erentially abundant taxa analysis 62.4.5 Inferred metagenomics 7Chapter 3. Results 83.1 Overall analysis workflow 83.2 Comparison between microbiota from group T from different mice strain 93.3 Comparison between microbiota from group TF and T (Exp. 1) 103.3.1 Overview of mice gut

microbiota 103.3.2 Gut microbial diversity of tumor-free and tumor-bearing mice 163.3.3 Significantly differential abundance taxonomies 263.3.4 Correlation of top 10 abundant bacterial taxonomies 313.3.5 PICRUSt2 predicted metabolic pathways according to gut microbiome 323.3.6 Firmicu

tes to Bacteroidates ratio 373.4 Tumor with BP treatment vs. Tumor 393.4.1 Overview of mice gut microbiota 393.4.2 Gut microbial diversity of tumor-bearing and with BP treatment tumor-bearing mice 443.4.3 Significantly differential abundance taxonomies 533.4.4 Correlation between the

abundance of top 10 taxa 553.4.5 PICRUSt2 predicted metabolic pathways inferred by gut microbiome gene 563.4.6 Association between the gut microbiota and tumor size 583.4.7 Firmicutes to Bacteroidetes ratio 61Chapter 4. Discussion 624.1 Gut microbiota and cancer 624.2 Gut microbiot

a and cancer therapies 624.3 Significantly differential abundance taxonomies in prostate cancer 634.4 Significantly differential abundance taxonomies in BP-treated prostate cancer 654.5 PICRUSt2 predicted gut microbial gene inferred pathways and prostate cancer 654.6 PICRUSt2 predicted g

ut microbial gene inferred pathways and prostate cancer with BP treatment 664.7 Correlation of taxa and tumor size 66Chapter5. Conclusion 68Chapter 6. Appendix 696.1 Formula of alpha diversity 696.2 Formula of beta diversity 70Reference 71